May 2005
Volume 46, Issue 13
ARVO Annual Meeting Abstract  |   May 2005
Vtreoretinal Surgery Under Retrobulbar Block Only
Author Affiliations & Notes
  • Y.H. Yoon
    Ophthalmology, Ulsan University Coll of Med, Seoul, Republic of Korea
    Ophthalmology, Asan Medical Center, Seoul, Republic of Korea
  • T. Lim
    Ophthalmology, Asan Medical Center, Seoul, Republic of Korea
  • M.S. Humayun
    Ophthalmology, Keck Medical School of Medicine, Doheny Eye Institute, Los Angeles, CA
  • Footnotes
    Commercial Relationships  Y.H. Yoon, None; T. Lim, None; M.S. Humayun, None.
  • Footnotes
    Support  Korean Ministry of Health and Welfare Grant 02–PJ1–PG1–CH02–0003
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 5433. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y.H. Yoon, T. Lim, M.S. Humayun; Vtreoretinal Surgery Under Retrobulbar Block Only . Invest. Ophthalmol. Vis. Sci. 2005;46(13):5433.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: The majority of vitreoretinal (VR) surgery is performed under general anesthesia or monitored anesthesia care. The purpose of this study was to demonstrate the scope of retrobulbar block only (RB) for VR surgery, to measure the acceptance of local anesthesia to patients and surgeons. Methods: Ninety patients who had undergone either 20G pars plana vitrectomy (PPV) or 25G transconjunctival sutureless vitrectomy (TSV25) were included. To determine the acceptability of RB to patients and surgeons, a clinical survey was carried out using a questionnaire and vital signs were monitored during operation. Surgical outcome was also assessed to confirm the validity of this practice pattern in clinical setting. Results: Under retrobulbar anesthesia only, 65 patients were treated with PPV and 25 with TSV25. Preoperative diagnoses included diabetic hemorrhage/RD/CSME in 49, macular pucker/hole/hemorrhage in 18, RD in 4, vein occlusion in 5, and others in 14 patients. In 25 patients, phacoemulsification and posterior IOL implantation was also combined. Mean operation time was 39 (range 20–60) minutes for TSV25 and 57 (30–150) minutes for PPV. Twenty–eight patients complained mild and 4 patietns moderate degree of pain during surgery. Among them 29 required either topical (15) or infiltrative (14) anesthesia additionally. There was no case of intraoperative complication because of movement of the patients. Increase of systolic blood pressure by 15 mmHg or higher occurred in 11 cases, and respiratory rate by 3 or more in 7 cases. Anatomical success rate was 95 % and visual improvement was achieved in 80%. Complications included a manageable retrobulbar bleeding in one case and postoperative neovascular glaucoma in 2 cases. Conclusions: We conclude that VR surgery can be safely and efficiently performed under retrobulbar block only. With the adoption of local anesthesia for TSV25, a new era of office–based VR surgery is just around the corner.

Keywords: vitreoretinal surgery 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.